These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16940956)

  • 1. [Studies on the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS M27-A2 microdilution method for azole susceptibility testing of Candida species].
    Uchida K; Nishiyama Y; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):209-17. PubMed ID: 16940956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study for testing the antifungal susceptibility of yeast by the Japanese Society for Medical Mycology (JSMM) method. The proposal of the modified JSMM method 2009].
    Nishiyama Y; Abe M; Ikeda R; Uno J; Oguri T; Shibuya K; Maesaki S; Mohri S; Yamada T; Ishibashi H; Hasumi Y; Abe S
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(3):153-63. PubMed ID: 20716854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.
    Arthington-Skaggs BA; Lee-Yang W; Ciblak MA; Frade JP; Brandt ME; Hajjeh RA; Harrison LH; Sofair AN; Warnock DW;
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2477-81. PubMed ID: 12121921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of susceptibility testing methods for micafungin: comparison of two microdilution methods].
    Abe M; Ogawa Z; Tanuma H; Yamazaki T; Kume H
    Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):111-8. PubMed ID: 18451592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
    Bernal S; Aller AI; Chávez M; Valverde A; Serrano C; Gutiérrez MJ; Quindós G; Martín Mazuelos E
    Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
    Martín-Mazuelos E; Gutiérrez MJ; Aller AI; Bernal S; Martínez MA; Montero O; Quindós G
    J Antimicrob Chemother; 1999 Apr; 43(4):477-81. PubMed ID: 10350375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species.
    Morace G; Amato G; Bistoni F; Fadda G; Marone P; Montagna MT; Oliveri S; Polonelli L; Rigoli R; Mancuso I; La Face S; Masucci L; Romano L; Napoli C; Tatò D; Buscema MG; Belli CM; Piccirillo MM; Conti S; Covan S; Fanti F; Cavanna C; D'Alò F; Pitzurra L
    J Clin Microbiol; 2002 Aug; 40(8):2953-8. PubMed ID: 12149358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified colorimetric assay for susceptibility testing of azole antifungal drugs against Candida species.
    Chen J; Wan Z; Li R
    J Clin Microbiol; 2004 Apr; 42(4):1790-3. PubMed ID: 15071052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of standard dilution method and commercial kit for frozen plate antifungal susceptibility testing of yeasts using 200 clinical isolates.
    Makimura K; Suzuki T; Tamura T; Ikedo M; Hanazawa R; Takahashi Y; Yamada Y; Uchida K; Yamaguchi H
    Microbiol Immunol; 2004; 48(10):747-53. PubMed ID: 15502407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controversies in the standardization of susceptibility testing on yeasts to azole antimycotics].
    Tintelnot K; Seibold M
    Mycoses; 1996; 39 Suppl 2():22-6. PubMed ID: 9198740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter evaluation of commercial frozen plates for microdilution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2.
    Makimura K; Oguri T; Mikami Y; Kume H; Hanazawa R; Abe M; Ikeda R; Shinoda T
    Microbiol Immunol; 2005; 49(2):97-106. PubMed ID: 15722594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Swinne D; Watelle M; Nolard N
    Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Fothergill A; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Sep; 43(9):4535-40. PubMed ID: 16145103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S; Sancak B; Hascelik G
    Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.
    Alexander BD; Byrne TC; Smith KL; Hanson KE; Anstrom KJ; Perfect JR; Reller LB
    J Clin Microbiol; 2007 Mar; 45(3):698-706. PubMed ID: 17202279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
    Nenoff P; Oswald U; Haustein UF
    Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Moore CB; Barchiesi F; Bille J; Chryssanthou E; Denning DW; Donnelly JP; Dromer F; Dupont B; Rex JH; Richardson MD; Sancak B; Verweij PE; Rodríguez-Tudela JL;
    Clin Microbiol Infect; 2003 Jun; 9(6):467-74. PubMed ID: 12848721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- versus 48-h incubation and 50 versus 80% reduction in growth.
    St-Germain G
    Mycoses; 2001; 44(1-2):37-45. PubMed ID: 11398639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.